Advertisement

The FDA Has Approved A New Alzheimer's Drug — Here's Why That's Controversial

Dr. William Burke goes over a PET brain scan in 2018 at Banner Alzheimer's Institute in Phoenix. The drug company Biogen has received federal approval for a medicine to treat early Alzheimer's disease. (AP)
Dr. William Burke goes over a PET brain scan in 2018 at Banner Alzheimer's Institute in Phoenix. The drug company Biogen has received federal approval for a medicine to treat early Alzheimer's disease. (AP)

This article was originally published on June 07, 2021.

Related:

Advertisement

More from WBUR

Listen Live
Close